Biotech

All Articles

AstraZeneca pays for CSPC $100M for preclinical heart problem medication

.AstraZeneca has settled CSPC Pharmaceutical Team $100 million for a preclinical heart attack medici...

Zephyrm looks for Hong Kong IPO to fund period 3 cell therapy tests

.Zephyrm Bioscience is gusting toward the Hong Kong stock market, submitting (PDF) for an IPO to mon...

Frazier Lifestyle Sciences gathers $630M for little, mid-cap biotechs

.Frazier Everyday life Sciences has actually sourced an even more $630 million for its fund concentr...

GigaGen achieves around $135M BARDA bucks to hammer botox

.Antitoxin fanatic GigaGen, a subsidiary of Spanish biopharma Grifols, is increase its own technolog...

GPCR firm Septerna declare IPO on strength of preclinical records

.Septerna is about to discover just how a biotech without "any meaningful professional information" ...

Kurma shuts first $154M haul for greatest biotech fund yet

.International VC company Kurma Allies has introduced its latest biotech fund, with 140 million euro...

Prothena promotes one director while yet another leaves-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of substantial leadership hirings, firings ...

Editas exploit Tip Cas9 licensing liberties for $57M

.Against the scenery of a Cas9 license struggle that refuses to die, Editas Medicine is actually mon...

Ultragenyx adjusts gene therapy dosing to call up efficacy

.A minority of people taking Ultragenyx Pharmaceutical's Wilson illness genetics therapy UX701 have ...

Biopharma layoff price stabilizes in Q3: Fierce Biotech evaluation

.As summer months warm looks to cool down winds, wishes that this year would deliver extensive marke...